Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
BioMarin Pharmaceutical
Information provided by (Responsible Party):
Heather Saavedra, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT01541397
First received: July 11, 2011
Last updated: February 23, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: October 2012
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)